David Launay Selected Research

Neoplasms (Cancer)

1/2022	The letter responds to comment on: Anti-PD(L)1 immunotherapies in patients with cancer and with pre-existing systemic sclerosis: a post-marketed safety assessment study.
1/2022	Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study.
1/2021	Serious Infectious Events and Immunoglobulin Replacement Therapy in Patients With Autoimmune Disease Receiving Rituximab: A Retrospective Cohort Study.
12/2014	Systemic sclerosis and prevalence of monoclonal immunoglobulin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Launay Research Topics

Disease

31	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2004
9	Pulmonary Arterial Hypertension 01/2021 - 02/2008
8	Pulmonary Hypertension 01/2021 - 01/2004
6	Hereditary Angioedemas 01/2022 - 06/2015
6	Angioedema 01/2022 - 06/2015
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 03/2011
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 06/2008
6	Vasculitis (Vasculitides) 01/2020 - 08/2011
5	Infections 10/2022 - 06/2012
4	Fibrosis (Cirrhosis) 11/2022 - 01/2004
4	Neoplasms (Cancer) 01/2022 - 12/2014
4	Arthritis (Polyarthritis) 09/2017 - 03/2011
3	Inflammation (Inflammations) 11/2022 - 04/2017
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2020 - 02/2008
3	Ischemia 10/2020 - 04/2006
3	Hemophilia A (Haemophilia) 01/2020 - 01/2006
3	Fever (Fevers) 01/2019 - 05/2006
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2018 - 08/2011
3	Rheumatic Diseases (Rheumatism) 01/2018 - 07/2010
3	Connective Tissue Diseases (Connective Tissue Disease) 01/2018 - 12/2006
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2021 - 11/2013
2	digital ulcers 10/2020 - 04/2006
2	Capillary Leak Syndrome 05/2020 - 07/2008
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2020 - 04/2019
2	Immunoglobulin G4-Related Disease 01/2020 - 01/2018
2	Heart Failure 01/2020 - 09/2010
2	Eosinophilia 01/2020 - 01/2020
2	Sarcoidosis (Schaumann Disease) 01/2020 - 08/2011
2	Thrombocytopenia (Thrombopenia) 01/2019 - 06/2016
2	Castleman Disease (Castleman's Disease) 01/2019 - 01/2018
2	Anemia 01/2019 - 06/2016
2	Telangiectasis (Telangiectasia) 01/2019 - 01/2018
2	Mixed Connective Tissue Disease (MCTD) 01/2018 - 02/2008
2	Schnitzler Syndrome 01/2018 - 01/2013
2	Thrombosis (Thrombus) 01/2018 - 12/2017
2	Bacterial Infections (Bacterial Infection) 07/2017 - 06/2014
2	Renal Insufficiency (Renal Failure) 01/2017 - 06/2014
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2016 - 08/2011
2	Immunoglobulin Light-chain Amyloidosis 08/2016 - 06/2012
2	Mastocytosis 06/2016 - 10/2015
2	Amyloidosis 08/2015 - 06/2012
2	Paraproteinemias (Monoclonal Gammopathy) 10/2014 - 01/2013
2	Rheumatoid Arthritis 06/2014 - 08/2011
2	Pericardial Effusion 09/2013 - 09/2010
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 10/2011 - 09/2007
1	Dyslipidemias (Dyslipidemia) 10/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2022
1	Colitis 05/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	VEXAS syndrome 01/2022

Drug/Important Bio-Agent (IBA)

13	AntibodiesIBA 06/2021 - 06/2010
12	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 04/2010
7	Rituximab (Mabthera)FDA Link 03/2021 - 01/2006
6	AutoantibodiesIBA 06/2021 - 09/2007
6	Biological ProductsIBA 01/2019 - 12/2002
5	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 09/2014
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 10/2006
4	Immunoglobulin G (IgG)IBA 10/2022 - 10/2007
4	C-Reactive ProteinIBA 04/2019 - 05/2006
4	Carbon MonoxideIBA 01/2019 - 09/2013
4	Immunoglobulin M (IgM)IBA 11/2018 - 01/2013
3	EnzymesIBA 01/2022 - 07/2010
3	BradykininIBA 01/2022 - 06/2015
3	SteroidsIBA 01/2021 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2014
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020 - 10/2011
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2017 - 05/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2017 - 09/2009
3	Amyloid (Amyloid Fibrils)IBA 08/2016 - 06/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2014 - 02/2008
3	Immunosuppressive Agents (Immunosuppressants)IBA 03/2011 - 02/2008
3	Bosentan (Tracleer)FDA Link 03/2010 - 04/2006
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 06/2012
2	Pharmaceutical PreparationsIBA 12/2020 - 01/2019
2	CreatinineIBA 01/2019 - 04/2010
2	CytokinesIBA 03/2018 - 01/2013
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2018 - 01/2018
2	Antiphospholipid AntibodiesIBA 01/2018 - 01/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 04/2017 - 07/2008
2	icatibantIBA 01/2017 - 08/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 09/2010
2	AA amyloidosisIBA 10/2014 - 05/2006
2	Rheumatoid FactorIBA 10/2011 - 09/2007
2	Sildenafil Citrate (Viagra)FDA Link 03/2010 - 12/2006
1	Immunoglobulin A (IgA)IBA 10/2022
1	CholesterolIBA 10/2022
1	LipidsIBA 10/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2022
1	Dextrans (Dextran)FDA Link 05/2022
1	AndrogensIBA 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022

Therapy/Procedure

10	Therapeutics 10/2022 - 06/2008
3	Aftercare (After-Treatment) 05/2020 - 06/2014
3	Transplantation 01/2020 - 04/2010
2	Hematopoietic Stem Cell Transplantation 01/2022 - 06/2014
2	Immunotherapy 01/2022 - 01/2022
1	Intradermal Injections 11/2022